HESTERBIO is an excellent buy....TARGET 2992The stock completed the 4th wave correction and started the 5th wave with a bang today. stock moved up up 13% on a bad day....stock has a target of 2995
21.70INR
266.27 MINR
2.66 BINR
2.48 M
About HESTER BIOSCIENCES
Sector
CEO
Rajiv Dinesh Gandhi
Headquarters
Ahmedabad
Website
Employees (FY)
693
Founded
1987
ISIN
INE782E01017
FIGI
BBG000DP7T17
Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. It operates through the following segments: Poultry Healthcare and Animal Healthcare. The Poultry Healthcare segment offers vaccines and health products for poultry animals. The Animal Healthcare segment provides vaccines and health products including, dugs, feed supplements, and disinfectants for large animals. The company was founded by Rajiv Dinesh Gandhi on April 29, 1987 and is headquartered in Ahmedabad, India.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HESTERBIO is 1612.05 INR — it has decreased by 0.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange HESTER BIOSCIENCES stocks are traded under the ticker HESTERBIO.
HESTER BIOSCIENCES is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
HESTERBIO stock is 1.13% volatile and has beta coefficient of 0.34. Check out the list of the most volatile stocks — is HESTER BIOSCIENCES there?
HESTERBIO earnings for the last quarter are 11.52 INR whereas the estimation was 14.31 INR which accounts for −19.50% surprise. Estimated earnings for the next quarter are 12.59 INR. See more details about HESTER BIOSCIENCES earnings.
HESTER BIOSCIENCES revenue for the last quarter amounts to 424.26 M INR despite the estimated figure of 502.94 M INR. In the next quarter revenue is expected to reach 466.69 M INR.
Yes, you can track HESTER BIOSCIENCES financials in yearly and quarterly reports right on TradingView.
HESTERBIO stock has risen by 2.86% compared to the previous week, the month change is a 16.06% rise, over the last year HESTER BIOSCIENCES has showed a 10.45% decrease.
HESTERBIO net income for the last quarter is 39.84 M INR, while the quarter before that showed 40.86 M INR of net income which accounts for −2.50% change. Track more HESTER BIOSCIENCES financial stats to get the full picture.
Today HESTER BIOSCIENCES has the market capitalization of 13.69 B, it has increased by 8.07% over the last week.
Yes, HESTERBIO dividends are paid annually. The last dividend per share was 8.00 INR. As of today, Dividend Yield (TTM)% is 0.50%. Tracking HESTER BIOSCIENCES dividends might help you take more informed decisions.
HESTER BIOSCIENCES dividend yield was 0.53% in 2022, and payout ratio reached 25.56%. The year before the numbers were 0.37% and 21.63% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, HESTERBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HESTER BIOSCIENCES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 693.00 employees. See our rating of the largest employees — is HESTER BIOSCIENCES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HESTER BIOSCIENCES technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HESTER BIOSCIENCES stock shows the neutral signal. See more of HESTER BIOSCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HESTER BIOSCIENCES EBITDA is 494.08 M INR, and current EBITDA margin is 19.44%. See more stats in HESTER BIOSCIENCES financial statements.